Zota Healthcare Fund Raise of ₹20.2 Cr
Zota Health Care invested ₹20.20 Crore in its subsidiary, Davaindia Health Mart, via a rights issue. This capital supports strategic store expansion and working capital needs.
- Value
- ₹20.20 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
37 announcements with these filters
Zota Health Care invested ₹20.20 Crore in its subsidiary, Davaindia Health Mart, via a rights issue. This capital supports strategic store expansion and working capital needs.
Zota Health Care recommended a 10% final dividend (Re. 1 per share) for FY2025-26. The payout remains subject to shareholder approval at the upcoming AGM.
Zota Health Care confirmed zero deviation in utilizing ₹722.50 Crore raised via preferential issues and QIP. Funds were fully deployed toward stated corporate and expansion objects.
Zota Healthcare Ltd reported revenue from operations of ₹163.2 Cr (+67.7% YoY) and a net loss of ₹14.5 Cr for Q4 FY26.
Zota Health Care reported FY26 consolidated revenue of ₹538.66 Crore and recommended a 10% dividend. The board also approved a ₹20.20 Crore investment in its subsidiary.
Zota Health Care appointed actor Akshay Kumar as brand ambassador for its UGO Generic brand. The partnership aims to expand affordable healthcare access across India.
Zota Health Care Limited confirmed full utilization of its ₹179.07 Crore preferential issue proceeds. CRISIL Ratings' report indicates zero unutilized funds as of March 31, 2026.